167 related articles for article (PubMed ID: 33630870)
1. A "ligand-targeting" peptide-drug conjugate: Targeted intracellular drug delivery by VEGF-binding helix-loop-helix peptides via receptor-mediated endocytosis.
Michigami M; Takahashi K; Yamashita H; Ye Z; Nakase I; Fujii I
PLoS One; 2021; 16(2):e0247045. PubMed ID: 33630870
[TBL] [Abstract][Full Text] [Related]
2. New Class of Drug Modalities: Directed Evolution of a De Novo Designed Helix-Loop-Helix Peptide to Bind VEGF for Tumor Growth Inhibition.
Michigami M; Ramanayake Mudiyanselage TMR; Suzuki M; Ishizako H; Notsu K; Sugiura K; Fujii I
ACS Chem Biol; 2022 Mar; 17(3):647-653. PubMed ID: 35176860
[TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
4. Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity.
Erdag B; Balcioglu KB; Kumbasar A; Celikbicak O; Zeder-Lutz G; Altschuh D; Salih B; Baysal K
Mol Biotechnol; 2007 Jan; 35(1):51-63. PubMed ID: 17401149
[TBL] [Abstract][Full Text] [Related]
5. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
6. Conformationally Constrained Peptides with High Affinity to the Vascular Endothelial Growth Factor.
Guryanov I; Korzhikov-Vlakh V; Bhattacharya M; Biondi B; Masiero G; Formaggio F; Tennikova T; Urtti A
J Med Chem; 2021 Aug; 64(15):10900-10907. PubMed ID: 34269584
[TBL] [Abstract][Full Text] [Related]
7. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
[TBL] [Abstract][Full Text] [Related]
8. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
Hossen MN; Kajimoto K; Akita H; Hyodo M; Ishitsuka T; Harashima H
J Control Release; 2010 Oct; 147(2):261-8. PubMed ID: 20647023
[TBL] [Abstract][Full Text] [Related]
9. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
10. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
Temming K; Meyer DL; Zabinski R; Dijkers EC; Poelstra K; Molema G; Kok RJ
Bioconjug Chem; 2006; 17(6):1385-94. PubMed ID: 17105215
[TBL] [Abstract][Full Text] [Related]
12. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.
Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G
Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226
[TBL] [Abstract][Full Text] [Related]
13. Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of Membrane Receptor for Constructing d-Peptide Mediated Targeted Drug Delivery Systems: A Case Study on Fn14.
Li Z; Xie J; Peng S; Liu S; Wang Y; Lu W; Shen J; Li C
Bioconjug Chem; 2017 Aug; 28(8):2167-2179. PubMed ID: 28715634
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Characterization of a High-Affinity Small Peptide Ligand, H1, Targeting FGFR2IIIc for Skin Wound Healing.
Zhao Y; Wang Q; Jin Y; Li Y; Nie C; Huang P; Li Z; Zhang B; Su Z; Hong A; Chen X
Cell Physiol Biochem; 2018; 49(3):1033-1048. PubMed ID: 30196288
[TBL] [Abstract][Full Text] [Related]
15. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
16. Integrin Targeting and Toxicological Assessment of Peptide-Conjugated Liposome Delivery Systems to Activated Endothelial Cells.
Kermanizadeh A; Villadsen K; Østrem RG; Jensen KJ; Møller P; Loft S
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):380-389. PubMed ID: 27767251
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
Burns KE; Robinson MK; Thévenin D
Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
[TBL] [Abstract][Full Text] [Related]
18. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
[TBL] [Abstract][Full Text] [Related]
19. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
20. A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library.
El-Mousawi M; Tchistiakova L; Yurchenko L; Pietrzynski G; Moreno M; Stanimirovic D; Ahmad D; Alakhov V
J Biol Chem; 2003 Nov; 278(47):46681-91. PubMed ID: 12954624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
